Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanna Finocchiaro

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 2, 2015
When is surgery indicated for small-cell lung cancer?Giulia Veronesi, Edoardo Bottoni, Giovanna Finocchiaro, et al.
Immunotherapy|June 15, 2019
Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experienceSabrina Rossi, Giovanna Finocchiaro, Luca Toschi, et al.
Ecancermedicalscience|December 12, 2017
Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to comeLuca Toschi, Sabrina Rossi, Giovanna Finocchiaro, et al.
Immunotherapy|June 12, 2020
Neutrophil and lymphocyte blood count as potential predictive indicators of nivolumab efficacy in metastatic non-small-cell lung cancerSabrina Rossi, Luca Toschi, Giovanna Finocchiaro, et al.
Immunotherapy|February 24, 2018
Checkpoint inhibitors: 'raising the bar' also in brain metastases from non-small-cell lung cancer?Sabrina Rossi, Giovanna Finocchiaro, Silvia Marchetti, et al.
Annals of Translational Medicine|May 21, 2015
Prognostic and predictive value of MET deregulation in non-small cell lung cancerGiovanna Finocchiaro, Luca Toschi, Letizia Gianoncelli, et al.
Drugs & Aging|July 24, 2003
Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigueGiovanni Pistone, Angela Marino, Carmelo Leotta, et al.
Cancers|May 11, 2024
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung CancerSabrina Rossi, Silvia Masini, Giovanna Finocchiaro, et al.
Oncology (Williston Park, N.Y.)|September 1, 2005
Perspectives on salvage therapy for non-small-cell lung cancerFederico Cappuzzo, Giovanna Finocchiaro, Rocco Trisolini, et al.
Digestive Diseases (Basel, Switzerland)|October 23, 2003
L-Carnitine in the treatment of mild or moderate hepatic encephalopathyMariano Malaguarnera, Giovanni Pistone, Marinella Astuto, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|November 2, 2015
When is surgery indicated for small-cell lung cancer?Giulia Veronesi, Edoardo Bottoni, Giovanna Finocchiaro, et al.
Immunotherapy|June 15, 2019
Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experienceSabrina Rossi, Giovanna Finocchiaro, Luca Toschi, et al.
Ecancermedicalscience|December 12, 2017
Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to comeLuca Toschi, Sabrina Rossi, Giovanna Finocchiaro, et al.
Immunotherapy|June 12, 2020
Neutrophil and lymphocyte blood count as potential predictive indicators of nivolumab efficacy in metastatic non-small-cell lung cancerSabrina Rossi, Luca Toschi, Giovanna Finocchiaro, et al.
Immunotherapy|February 24, 2018
Checkpoint inhibitors: 'raising the bar' also in brain metastases from non-small-cell lung cancer?Sabrina Rossi, Giovanna Finocchiaro, Silvia Marchetti, et al.
Annals of Translational Medicine|May 21, 2015
Prognostic and predictive value of MET deregulation in non-small cell lung cancerGiovanna Finocchiaro, Luca Toschi, Letizia Gianoncelli, et al.
Drugs & Aging|July 24, 2003
Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigueGiovanni Pistone, Angela Marino, Carmelo Leotta, et al.
Cancers|May 11, 2024
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung CancerSabrina Rossi, Silvia Masini, Giovanna Finocchiaro, et al.
Oncology (Williston Park, N.Y.)|September 1, 2005
Perspectives on salvage therapy for non-small-cell lung cancerFederico Cappuzzo, Giovanna Finocchiaro, Rocco Trisolini, et al.
Digestive Diseases (Basel, Switzerland)|October 23, 2003
L-Carnitine in the treatment of mild or moderate hepatic encephalopathyMariano Malaguarnera, Giovanni Pistone, Marinella Astuto, et al.
Pageof 5